Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
Conditions: Bariatric Surgery Candidate; Bone Loss Interventions: Drug: Denosumab; Drug: Placebo Sponsors: Massachusetts General Hospital; University of California, San Francisco; San Francisco VA Health Care System Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials